BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 34673895)

  • 1. Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
    ; Munch MW; Myatra SN; Vijayaraghavan BKT; Saseedharan S; Benfield T; Wahlin RR; Rasmussen BS; Andreasen AS; Poulsen LM; Cioccari L; Khan MS; Kapadia F; Divatia JV; Brøchner AC; Bestle MH; Helleberg M; Michelsen J; Padmanaban A; Bose N; Møller A; Borawake K; Kristiansen KT; Shukla U; Chew MS; Dixit S; Ulrik CS; Amin PR; Chawla R; Wamberg CA; Shah MS; Darfelt IS; Jørgensen VL; Smitt M; Granholm A; Kjær MN; Møller MH; Meyhoff TS; Vesterlund GK; Hammond NE; Micallef S; Bassi A; John O; Jha A; Cronhjort M; Jakob SM; Gluud C; Lange T; Kadam V; Marcussen KV; Hollenberg J; Hedman A; Nielsen H; Schjørring OL; Jensen MQ; Leistner JW; Jonassen TB; Kristensen CM; Clapp EC; Hjortsø CJS; Jensen TS; Halstad LS; Bak ERB; Zaabalawi R; Metcalf-Clausen M; Abdi S; Hatley EV; Aksnes TS; Gleipner-Andersen E; Alarcón AF; Yamin G; Heymowski A; Berggren A; La Cour K; Weihe S; Pind AH; Engstrøm J; Jha V; Venkatesh B; Perner A
    JAMA; 2021 Nov; 326(18):1807-1817. PubMed ID: 34673895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
    Tomazini BM; Maia IS; Cavalcanti AB; Berwanger O; Rosa RG; Veiga VC; Avezum A; Lopes RD; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Damiani LP; Lisboa T; Kawano-Dourado L; Zampieri FG; Olivato GB; Righy C; Amendola CP; Roepke RML; Freitas DHM; Forte DN; Freitas FGR; Fernandes CCF; Melro LMG; Junior GFS; Morais DC; Zung S; Machado FR; Azevedo LCP;
    JAMA; 2020 Oct; 324(13):1307-1316. PubMed ID: 32876695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan.
    Munch MW; Granholm A; Myatra SN; Vijayaraghavan B; Cronhjort M; Wahlin RR; Jakob SM; Cioccari L; Kjaer MN; Vesterlund GK; Meyhoff TS; Helleberg M; Møller MH; Benfield T; Venkatesh B; Hammond N; Micallef S; Bassi A; John O; Jha V; Kristiansen KT; Ulrik CS; Jørgensen VL; Smitt M; Bestle MH; Andreasen AS; Poulsen LM; Rasmussen BS; Brøchner AC; Strøm T; Møller A; Khan MS; Padmanaban A; Divatia JV; Saseedharan S; Borawake K; Kapadia F; Dixit S; Chawla R; Shukla U; Amin P; Chew MS; Gluud C; Lange T; Perner A
    Acta Anaesthesiol Scand; 2021 Jul; 65(6):834-845. PubMed ID: 33583034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial.
    Grieco DL; Menga LS; Cesarano M; Rosà T; Spadaro S; Bitondo MM; Montomoli J; Falò G; Tonetti T; Cutuli SL; Pintaudi G; Tanzarella ES; Piervincenzi E; Bongiovanni F; Dell'Anna AM; Delle Cese L; Berardi C; Carelli S; Bocci MG; Montini L; Bello G; Natalini D; De Pascale G; Velardo M; Volta CA; Ranieri VM; Conti G; Maggiore SM; Antonelli M;
    JAMA; 2021 May; 325(17):1731-1743. PubMed ID: 33764378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
    Lopes RD; Macedo AVS; de Barros E Silva PGM; Moll-Bernardes RJ; Dos Santos TM; Mazza L; Feldman A; D'Andréa Saba Arruda G; de Albuquerque DC; Camiletti AS; de Sousa AS; de Paula TC; Giusti KGD; Domiciano RAM; Noya-Rabelo MM; Hamilton AM; Loures VA; Dionísio RM; Furquim TAB; De Luca FA; Dos Santos Sousa ÍB; Bandeira BS; Zukowski CN; de Oliveira RGG; Ribeiro NB; de Moraes JL; Petriz JLF; Pimentel AM; Miranda JS; de Jesus Abufaiad BE; Gibson CM; Granger CB; Alexander JH; de Souza OF;
    JAMA; 2021 Jan; 325(3):254-264. PubMed ID: 33464336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial.
    Bouadma L; Mekontso-Dessap A; Burdet C; Merdji H; Poissy J; Dupuis C; Guitton C; Schwebel C; Cohen Y; Bruel C; Marzouk M; Geri G; Cerf C; Mégarbane B; Garçon P; Kipnis E; Visseaux B; Beldjoudi N; Chevret S; Timsit JF;
    JAMA Intern Med; 2022 Sep; 182(9):906-916. PubMed ID: 35788622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    ; Estcourt LJ; Turgeon AF; McQuilten ZK; McVerry BJ; Al-Beidh F; Annane D; Arabi YM; Arnold DM; Beane A; Bégin P; van Bentum-Puijk W; Berry LR; Bhimani Z; Birchall JE; Bonten MJM; Bradbury CA; Brunkhorst FM; Buxton M; Callum JL; Chassé M; Cheng AC; Cove ME; Daly J; Derde L; Detry MA; De Jong M; Evans A; Fergusson DA; Fish M; Fitzgerald M; Foley C; Goossens H; Gordon AC; Gosbell IB; Green C; Haniffa R; Harvala H; Higgins AM; Hills TE; Hoad VC; Horvat C; Huang DT; Hudson CL; Ichihara N; Laing E; Lamikanra AA; Lamontagne F; Lawler PR; Linstrum K; Litton E; Lorenzi E; MacLennan S; Marshall J; McAuley DF; McDyer JF; McGlothlin A; McGuinness S; Miflin G; Montgomery S; Mouncey PR; Murthy S; Nichol A; Parke R; Parker JC; Priddee N; Purcell DFJ; Reyes LF; Richardson P; Robitaille N; Rowan KM; Rynne J; Saito H; Santos M; Saunders CT; Serpa Neto A; Seymour CW; Silversides JA; Tinmouth AA; Triulzi DJ; Turner AM; van de Veerdonk F; Walsh TS; Wood EM; Berry S; Lewis RJ; Menon DK; McArthur C; Zarychanski R; Angus DC; Webb SA; Roberts DJ; Shankar-Hari M
    JAMA; 2021 Nov; 326(17):1690-1702. PubMed ID: 34606578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial.
    Alhazzani W; Parhar KKS; Weatherald J; Al Duhailib Z; Alshahrani M; Al-Fares A; Buabbas S; Cherian SV; Munshi L; Fan E; Al-Hameed F; Chalabi J; Rahmatullah AA; Duan E; Tsang JLY; Lewis K; Lauzier F; Centofanti J; Rochwerg B; Culgin S; Nelson K; Abdukahil SA; Fiest KM; Stelfox HT; Tlayjeh H; Meade MO; Perri D; Solverson K; Niven DJ; Lim R; Møller MH; Belley-Cote E; Thabane L; Tamim H; Cook DJ; Arabi YM;
    JAMA; 2022 Jun; 327(21):2104-2113. PubMed ID: 35569448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone in Hospitalized Patients with Covid-19.
    ; Horby P; Lim WS; Emberson JR; Mafham M; Bell JL; Linsell L; Staplin N; Brightling C; Ustianowski A; Elmahi E; Prudon B; Green C; Felton T; Chadwick D; Rege K; Fegan C; Chappell LC; Faust SN; Jaki T; Jeffery K; Montgomery A; Rowan K; Juszczak E; Baillie JK; Haynes R; Landray MJ
    N Engl J Med; 2021 Feb; 384(8):693-704. PubMed ID: 32678530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
    Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
    Murai IH; Fernandes AL; Sales LP; Pinto AJ; Goessler KF; Duran CSC; Silva CBR; Franco AS; Macedo MB; Dalmolin HHH; Baggio J; Balbi GGM; Reis BZ; Antonangelo L; Caparbo VF; Gualano B; Pereira RMR
    JAMA; 2021 Mar; 325(11):1053-1060. PubMed ID: 33595634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    ; Bradbury CA; Lawler PR; Stanworth SJ; McVerry BJ; McQuilten Z; Higgins AM; Mouncey PR; Al-Beidh F; Rowan KM; Berry LR; Lorenzi E; Zarychanski R; Arabi YM; Annane D; Beane A; van Bentum-Puijk W; Bhimani Z; Bihari S; Bonten MJM; Brunkhorst FM; Buzgau A; Buxton M; Carrier M; Cheng AC; Cove M; Detry MA; Estcourt LJ; Fitzgerald M; Girard TD; Goligher EC; Goossens H; Haniffa R; Hills T; Huang DT; Horvat CM; Hunt BJ; Ichihara N; Lamontagne F; Leavis HL; Linstrum KM; Litton E; Marshall JC; McAuley DF; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Morpeth SC; Murthy S; Neal MD; Nichol AD; Parke RL; Parker JC; Reyes LF; Saito H; Santos MS; Saunders CT; Serpa-Neto A; Seymour CW; Shankar-Hari M; Singh V; Tolppa T; Turgeon AF; Turner AM; van de Veerdonk FL; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Derde LPG; Webb SA; Gordon AC
    JAMA; 2022 Apr; 327(13):1247-1259. PubMed ID: 35315874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
    Hermine O; Mariette X; Tharaux PL; Resche-Rigon M; Porcher R; Ravaud P;
    JAMA Intern Med; 2021 Jan; 181(1):32-40. PubMed ID: 33080017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone doses in patients with COVID-19 and hypoxia: A systematic review and meta-analysis.
    Munch MW; Granholm A; Maláska J; Stašek J; Rodriguez PO; Pitre T; Wilson R; Savović J; Rochwerg B; Svobodnik A; Kratochvíl M; Taboada M; Jha V; Vijayaraghavan BKT; Myatra SN; Venkatesh B; Perner A; Møller MH
    Acta Anaesthesiol Scand; 2024 Feb; 68(2):146-166. PubMed ID: 37881881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
    Caricchio R; Abbate A; Gordeev I; Meng J; Hsue PY; Neogi T; Arduino R; Fomina D; Bogdanov R; Stepanenko T; Ruiz-Seco P; Gónzalez-García A; Chen Y; Li Y; Whelan S; Noviello S;
    JAMA; 2021 Jul; 326(3):230-239. PubMed ID: 34283183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis.
    Granholm A; Munch MW; Myatra SN; Vijayaraghavan BKT; Cronhjort M; Wahlin RR; Jakob SM; Cioccari L; Kjaer MN; Vesterlund GK; Meyhoff TS; Helleberg M; Møller MH; Benfield T; Venkatesh B; Hammond N; Micallef S; Bassi A; John O; Jha V; Kristiansen KT; Ulrik CS; Jørgensen VL; Smitt M; Bestle MH; Andreasen AS; Poulsen LM; Rasmussen BS; Brøchner AC; Strøm T; Møller A; Khan MS; Padmanaban A; Divatia JV; Saseedharan S; Borawake K; Kapadia F; Dixit S; Chawla R; Shukla U; Amin P; Chew MS; Gluud C; Lange T; Perner A
    Acta Anaesthesiol Scand; 2021 May; 65(5):702-710. PubMed ID: 33583027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.